62 related articles for article (PubMed ID: 20819644)
1. Arsenic trioxide up-regulates Fas expression in human osteosarcoma cells.
Yang GF; Li XH; Zhao Z; Wang WB
Chin Med J (Engl); 2010 Jul; 123(13):1768-73. PubMed ID: 20819644
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
3. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M
Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Wu DD; Xiao YF; Geng Y; Hou J
Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
[TBL] [Abstract][Full Text] [Related]
9. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
[TBL] [Abstract][Full Text] [Related]
10. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
11. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
12. Anion exchanger 2 mediates the action of arsenic trioxide.
Pan XY; Chen GQ; Cai L; Buscemi S; Fu GH
Br J Haematol; 2006 Sep; 134(5):491-9. PubMed ID: 17018029
[TBL] [Abstract][Full Text] [Related]
13. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
Zhang T; Wang SS; Hong L; Wang XL; Qi QH
J Exp Clin Cancer Res; 2003 Mar; 22(1):61-8. PubMed ID: 12725324
[TBL] [Abstract][Full Text] [Related]
16. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
Xie XK; Yang DS; Ye ZM; Tao HM
Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis.
Chiu HW; Lin W; Ho SY; Wang YJ
Radiat Res; 2011 May; 175(5):547-60. PubMed ID: 21388295
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8.
Inaba H; Glibetic M; Buck S; Ravindranath Y; Kaplan J
Pediatr Blood Cancer; 2004 Dec; 43(7):729-36. PubMed ID: 15390286
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells.
Chow SK; Chan JY; Fung KP
J Cell Biochem; 2004 Sep; 93(1):173-87. PubMed ID: 15352174
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Li X; Ding X; Adrian TE
Anticancer Res; 2002; 22(4):2205-13. PubMed ID: 12174905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
